Spelling suggestions: "subject:"prostate aancer"" "subject:"prostate 7cancer""
241 |
Mäns upplevelser av att leva med prostatacancer / Men's experiences living with prostate cancerJansson, Marco, Johansson, Alexander January 2016 (has links)
Prostatacancer är en cancerform som drabbar män i övre medelåldern. Cancerformen påverkar patienter både fysiskt och psykiskt genom symtom och biverkningar från behandling. Syftet med litteraturstudien var att beskriva hur patienter som behandlas för prostatacancer upplever sin situation. Studiens resultat utgick ifrån tio vetenskapliga artiklar som besvarade studiens syfte. Resultatet bearbetades och resulterade i fem kategorier: socialt stöd, brist på information, emotionell påverkan, förändrad sexualitet och upplevelse av behandlingspåverkan. I resultatet framkom det att stöd från vänner, familj och sjukvård var en viktig del i hanteringen av sjukdomen samt att patienter med prostatacancer upplevde informationsbrist från sjukvården. Patienterna upplevde en emotionell påverkan både fysiskt och psykiskt som beskrevs som oro och depression. Sexualiteten blev förändrad hos de flesta patienterna som genomgått behandling samt att de olika behandlingarna gav biverkningar som kunde vara svåra att hantera. Tidigare forskning visar att patienter upplever att de är bristfälligt informerade om prostatacancer och dess behandlingar. Därför bör ytterligare forskning fokusera på varför det är en informationsbrist från sjukvården och samhället. / Prostate cancer is a form of cancer that men in the upper middle age fall victim to. This cancer form affects the patients both physically and mentally through symptoms and side effects from the treatment. The aim of the literature study was to describe how patients, who have been treated for prostate cancer, experience their situation. The result of the study was based on ten scientific articles which answered the purpose of the study. The result was processed and it resulted in five categories: social support, lack of information, emotional impact, changed sexuality and experience of treatment. The result showed that support from family and health care was an important part in dealing with the disease and that patients with prostate cancer felt a lack of information from health services. The patients experienced an emotional effect on both their physical and mental health, described as anxiety and depression. Sexuality changed for most of the patients who went through treatment, and the different treatments caused side effects that could be difficult to deal with. Previous research show that patients are not fully informed about prostate cancer and its treatments. For this reason further research should focus on why there is a lack of information from the health services and the society.
|
242 |
Role of UCHL1 in regulating gene expression in prostate cancer cellsIlic, Aleksandar 28 August 2014 (has links)
Ubiquitin C-terminal hydrolase L1 (UCHL1) is a multifunctional protein primarily expressed in neuronal cells and involved in numerous cellular processes. UCHL1 has been linked with neurodegenerative diseases and a wide range of cancers but its specific role remains unknown. Previous UCHL1 knockdown studies have shown that UCHL1 controls the expression of pro- and anti-apoptotic genes as well as genes involved in cell cycle regulation but it is unknown how UCHL1 regulates these genes.
We have shown that UCHL1 is cross-linked to DNA in DU145 but not in LNCaP or PC3 prostate cancer cells. Therefore, we hypothesized that UCHL1 regulates the expression of pro- or anti-apoptotic genes as well as the genes involved in the cell cycle through its interaction with DNA. By utilizing ChIP and ChIP-seq analyses it is possible to determine the UCHL1 target sequences on the genomic DNA.
It was shown that UCHL1 is only expressed in DU145 but not in LNCaP, PC3 or C4-2 prostate cancer cell lines. Additionally, UCHL1 is expressed and cross-linked to DNA in HEK293T cells. It is believed that UCHL1 is silenced by upstream promoter methylation when it is not expressed. However, treatment with the epigenetic drugs 5-aza-2′-deoxycytidine and trichostatin A (TSA) did not result in induction of UCHL1 expression in LNCaP, PC3 or C4-2 prostate cancer cell lines.
UCHL1 is also associated with p53. However, ChIP assay results have shown that UCHL1 and p53 do not bind to genomic DNA of upstream promoter regions CDKN1A and BAX genes. Additionally, through UCHL1 ChIP-seq analyses in DU145 and HEK293T cells, we discovered that UCHL1 co-localizes to the DNA with the shelterin complex shedding light on a new role of UCHL1 that has never been described before. / October 2014
|
243 |
An investigation into the influence of rooibos (Aspalathus linearis) on androgen metabolism in normal and prostate cancer cellsDu Toit, Therina 04 1900 (has links)
Thesis (MSc)--Stellenbosch University, 2015. / ENGLISH ABSTRACT: In this study, the influence of rooibos on the catalytic activity of enzymes 17β -hydroxysteroid dehydrogenase type 3 (17βHSD3), 17β-hydroxysteroid dehydrogenase type 5 (AKR1C3),
17β-hydroxysteroid dehydrogenase type 2 (17βHSD2), 5α-reductase type 1 (SRD5A1) and
5α-reductase type 2 (SRD5A2), which catalyse prostate androgen metabolism, was investigated.
The activities of both 17βHSD3 and AKR1C3 heterologously expressed in CHO-K1 and HEK293
cells were inhibited significantly by rooibos, with rooibos reducing the conversion of
androstenedione (A4) and 11keto-androstenedione (11KA4) to testosterone (T) and 11ketotestosterone
(11KT), respectively. The catalytic activity of 17βHSD2 towards T, 11hydroxytestosterone
(11OHT) and 11KT was also significantly inhibited by rooibos in transiently
transfected HEK293 cells. In transiently transfected HEK293 cells rooibos did not inhibit SRD5A1
while the rate of T conversion to dihydrotestosterone (DHT) by SRD5A2 was decreased. Analysis
of steroid metabolism in PNT2 cells also suggests that rooibos does not modulate the catalytic
activity of endogenously expressed SRD5A towards A4, however, the conversion of T to DHT was
reduced. In addition, reductive 17βHSD activity towards A4 was inhibited in the presence of
rooibos in both PNT2 and BPH-1 cells. In contrast, the conversion of 11KA4 to 11KT was inhibited
in BPH-1, PC-3 and LNCaP cells, with negligible conversion of 11KA4 in PNT2 cells. Interestingly,
data suggests inhibition of 3α-hydroxysteroid dehydrogenase type 3 (AKR1C2) activity in the
production of androsterone (AST) from 5α–androstenedione (5α-dione), as well as the dehydrogenase reaction of T to A4 in PNT2 cells by rooibos. Androgen metabolism pathways were
subsequently investigated in LNCaP cells to determine androgen metabolism by endogenous
enzymes. Rooibos resulted in the reduced conversion of A4 in LNCaP cells to the same extent as
indomethacin, a known AKR1C3 inhibitor. Rooibos also modulated T, DHT and AST metabolism in
LNCaP cells. Furthermore, uridine diphosphate glucuronosyltransferase (UGT) activity in LNCaP
cells was inhibited by rooibos, decreasing T-, DHT– and AST-glucuronide formation. These data
prompted subsequent investigations into the influence of rooibos at cellular level, and prostatespecific
antigen (PSA) levels were assayed in the presence of rooibos. PSA was significantly
inhibited by rooibos in the absence and presence of DHT, suggesting possible interaction of
rooibos with the mutated androgen receptor (AR) or estrogen receptor-β (ERβ) expressed in
LNCaP cells.
Taken together, rooibos inhibited the catalytic activity of key enzymes that catalyse the activation
of androgens in the prostate, as well as inhibiting enzymes involved in the conjugation of
androgens. At cellular level, PSA levels were also decreased by rooibos, possibly through AR or
ERβ interactions – clearly indicating a modulatory role for rooibos in active androgen production. / AFRIKAANSE OPSOMMING: In hierdie studie was die invloed van rooibos ten opsigte van die katalitiese aktiwiteite van die
ensieme 17β-hidroksi-steroïed-dehidrogenase tipe 2, tipe 3 en tipe 5 (17βHSD2, 17βHSD3,
AKR1C3), asook 5α-reduktase tipe 1 en tipe 2 (SRD5A1, SRD5A2) ondersoek. Hierdie ensieme is
betrokke in die produksie van androgene in die prostaat. Rooibos het die katalitiese aktiwiteit van
17βHSD3 en AKR1C3 in CHO-K1 en HEK293 selle beïnvloed en het vermindere omskakeling van
androstenedioon (A4) en 11keto-androstenedioon (11KA4) na testosteroon (T) en 11-ketotestosteroon
(11KT), afsonderlik, veroorsaak. Die katalitiese aktiwiteit van 17βHSD2 teenoor T,
11-hidroksie-testosteroon (11OHT) en 11KT was ook beïnvloed in die teenwoordigheid van rooibos
in HEK293 selle. Die katalitiese aktiwiteit van SRD5A1 teenoor A4 en T is nie beïnvloed deur
rooibos nie, alhoewel dit voorkom asof rooibos die omsettingstempo van T na dihidrotestosteroon
(DHT) deur SRD5A2, getransfekteer in HEK293 selle, verminder het. Verdere ondersoeke is in
normale prostaat epiteel selle, in die teenwoordigheid van rooibos uitgevoer. Rooibos het geen
invloed op die katalitiese aktiwiteit van SRD5A teenoor A4 gehad nie, alhoewel vermindere
omskakeling van T na DHT aangetoon kon word. Rooibos het ook die omskakeling van A4 na T in
beide PNT2 en BPH-1 selle tot „n mate geïnhibeer. Die omskakeling van 11KA4 na 11KT was ook
verminder in BPH-1, PC-3 en LNCaP selle. Die omskakeling van 11KA4 na 11KT was beduidend
laer in PNT2 selle en kon die invloed van rooibos nie aangetoon word nie. Bykomende data toon
dat rooibos ook die omskakeling van 5α-androstenedioon (5α-dione) na androsteroon (AST),
gekataliseer deur 3α-hidroksi-dehidrogenase tipe 3 (AKR1C2), verminder, gesamentlik met die
vermindere omskakeling van T na A4, deur 17βHSD2, in PNT2 selle. Hierdie studie het ook
ondersoek ingestel, na die metabolisme van androgene in LNCaP selle. Vermindere A4
metabolisme is in die teenwoordigheid van rooibos asook in die teenwoordigheid van
indometasien, „n bekende AKR1C3 inhibitor, gevind. Rooibos verminder dus die aktiwiteit van
reduktiewe 17βHSD in LNCaP selle. Verandering in die metabolisme van T, DHT en AST in
LNCaP selle, in die teenwoordigheid van rooibos, is ook gevind. Verdere ondersoek in LNCaP
selle het gewys dat rooibos „n vermindering in die produksie van gekonjugeerde T, DHT en AST
veroorsaak. Die studie het die invloed van rooibos op prostaat-spesifieke antigeen (PSA) ook
ondersoek. Daar is vasgestel dat rooibos die vlakke van PSA verminder in die afwesigheid en
teenwoordigheid van DHT in LNCaP selle. Hierdie resultaat dui op moontlike interaksie van
rooibos met die androgeen (AR) of estrogeen-reseptor-β (ERβ), teenwoordig in LNCaP selle.
Rooibos het die katalitiese aktiwiteit van ensieme, wat bydra tot androgeen produksie, geïnhibeer,
asook die konjugasie van androgene. Op „n sellulêre vlak, het rooibos die vlakke van PSA-sekresie
verminder, wat moontlike interaksie met die AR en ERβ aandui. Hierdie bevindings dui daarop dat
rooibos wel n rol het om te speel in die modulasie van aktiewe androgene in die prostaat.
|
244 |
The characterisation of the catalytic activity of human steroid 5α-reductase towards novel C19 substratesQuanson, Jonathan Luke 04 1900 (has links)
Thesis (MSc)--Stellenbosch University, 2015. / ENGLISH ABSTRACT: This study describes:
• The UPLC-MS/MS analyses and quantification of novel 5α-reduced steroids using
response factors.
• The kinetic characterisation of human steroid 5α-reductase type 1 (SRD5A1),
expressed in HEK-293 cells, towards 11OHA4 and 11OHT and their keto derivatives
by progress curve analysis.
• The subcloning, transformation and functional expression of SRD5A1 in the yeast
expression system, P. pastoris.
• The conversion of 11OHA4 and 11OHT and their keto derivatives by SRD5A1
expressed in P. pastoris.
• The endogenous enzymatic activity in P. pastoris towards the 5α-reduced metabolites
in the 11OHA4- and alternate 5α-dione pathways.
• The potential application of P. pastoris as a biocatalyst in the production of 5α-
reduced C19 steroids. / AFRIKAANSE OPSOMMING: Hierdie ondersoek beskryf:
• Die UPLC-MS/MS analise en kwantifisering van nuut-ondekte 5α-gereduseerde
steroïede met behulp van responsfaktore.
• Die kinetiese karakterisering van menslike steroïed 5α-reduktase tipe 1 (SRD5A1),
uitgedruk in HEK-293 selle, vir 11OHA4 en 11OHT en hul ketoderivate deur middel
van progressiekurwe-analise.
• Die subklonering, transformasie en funksionele uitdrukking van SRD5A1 in die gis
P. pastoris.
• Die omsetting van 11OHA4 en 11OHT en hul ketoderivate deur SRD5A1 uitgedruk in
P. pastoris.
• Die omsetting van 5α-gereduseerde steroïede in die 11OHA4 en alternatiewe 5α-dioon
paaie deur endogene ensieme in P. pastoris
• ‘n Ondersoek na die toepassing van die gisuitdrukkingstelsel as ‘n moontlike OR
potensiële biokatalis vir die produksie van 5α-gereduseerde C19 steroïede.
|
245 |
MAD2 inactivation on chromosomal instability and tumorigenesis in prostate epithelial cellsTo, Kit-wa, 杜潔華 January 2007 (has links)
published_or_final_version / abstract / Anatomy / Doctoral / Doctor of Philosophy
|
246 |
Oncogenic function of TWIST in the development and progression of prostate cancerKwok, Wai-kei., 郭慧琪. January 2007 (has links)
published_or_final_version / abstract / Anatomy / Doctoral / Doctor of Philosophy
|
247 |
Secreted PDZ domain-containing protein 2 (sPDZD2): a potential autocrine tumor suppressorTam, Chun-wai., 談振偉. January 2007 (has links)
published_or_final_version / abstract / Physiology / Doctoral / Doctor of Philosophy
|
248 |
Antiproliferative actions of melatonin and secreted PDZ domain-containing protein 2 (sPDZD2) on tumor cellsPang, Bo., 龐博. January 2009 (has links)
published_or_final_version / Physiology / Master / Master of Philosophy
|
249 |
THE RADIOSENSITIZATION EFFECT OF PARTHENOLIDE IN PROSTATE CANCER: IMPLICATIONS FOR SELECTIVE CANCER KILLING BY MODULATION OF INTRACELLULAR REDOX STATESun, Yulan 01 January 2010 (has links)
Parthenolide (PN), a major active component of the traditional herbal medicine feverfew, has been shown to have anti-inflammatory and anti-tumor properties. More remarkably, the cytotoxicity of PN seems selective to tumor cells but not their normal cell counterparts. In the present study, we investigate whether and how PN selectively enhances tumor sensitivity to radiation therapy by using prostate cancer cells LNCaP, DU145 and PC3, as well as normal prostate epithelial cells PrEC.
Our study demonstrates that inhibition of NF-κB pathway and suppression of its downstream target MnSOD are common mechanisms for the radiosensitization effect of PN in prostate cancer cells. The differential susceptibility to PN in two radioresistant cancer cells, DU145 and PC3, is due, in part, to the fact that in addition to NF-κB inhibition, PN activates the PI3K/Akt pro-survival pathway in both cell lines. The presence of PTEN in DU145 cells enhances the radiosensitization effect of PN by suppression of the steady state level of activated p-Akt.
We also demonstrate that PN selectively exhibits a radiosensitization effect on prostate cancer PC3 cells but not on normal prostate epithelial PrEC cells. PN causes oxidative stress in PC3 cells but not in PrEC cells, as determined by the oxidation of the ROS-sensitive probe H2DCFDA and intracellular reduced thiol and disulfide levels. In PC3 but not PrEC cells, PN activates NADPH oxidase leading to a decrease in the level of reduced thioredoxin, activation of PI3K/Akt and consequent FOXO3a phosphorylation, which results in the downregulation of FOXO3a targets, antioxidant enzyme MnSOD and catalase. Importantly, when combined with radiation, PN further increases ROS levels in PC3 cells, while it decreases radiation-induced oxidative stress in PrEC cells, possibly by increasing GSH level.
Overall, our data support the concept that increasing oxidative stress in cancer cells, which are already under high constitutive oxidative stress, will lead to cell death, while the same stress may allow normal cells to maintain redox homeostasis through adaptive response. Thus, modulating cell redox status may be a novel approach to efficiently and selectively kill cancer cells.
|
250 |
Prostate cancer prevention and early detection decisions among black males less than 40 years oldOgunsanya, Motolani Eniola 10 October 2014 (has links)
The purpose of this study was to determine the factors related to young black men’s intention to screen for prostate cancer as well as their engagement in prostate cancer risk-reduction behaviors. The study tested the significance of the constructs – age, attitude (direct and indirect), social influence, comfortability, cues to action, health screening experiences and knowledge – in predicting young black men’s intention to screen for prostate cancer; as well as the significance of the constructs – age, cues to action, exercise and knowledge – in predicting engagement in prostate cancer risk-reduction behaviors. Demographic/personal factors were also explored in related to the model predictors. Web-based and paper-pencil surveys were administered to 279 black men aged between 18 – 40 years from the Austin area. Three focus groups were conducted to collect information regarding young black men’s behavioral beliefs toward prostate cancer screening as well as their comfortability with prostate examinations. The number of usable surveys was 267. Using direct and indirect measures, the combination of attitude, social influence, comfortability (indirect model), and knowledge explained 41.0 and 43.0 percent of the variance in intention to screen for prostate cancer, respectively; with social influence being the strongest predictor ([Beta]=0.41; p <0.01 for the direct model and [Beta]=0.47 for the indirect model). For the model with prostate cancer risk-reduction as the outcome variable, the model accounted for 10.0 percent of the variance in behavior with only knowledge ([Beta]=0.19; p=0.03) as significant predictor. Interventions that address young black men’s attitude, social influence, comfortability, and knowledge may be necessary to increase young men’s intention to screen for prostate cancer when it is recommended by a physician. Additionally, factors surrounding exercise and knowledge may be important in increasing young men’s engagement in prostate cancer risk-reduction behaviors. Future studies using intention as a predictor of young men’s behavior are needed to assess the influence of intention on prostate cancer screening. / text
|
Page generated in 0.0756 seconds